BioSpace News Archive

Program to help sub-acute patients in Chicopee and the Greater Springfield area with respiratory ailments to breathe and function at highest level possible.

Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical Next Generation Sequencing (NGS), announced that the company’s laboratory completed the Clinical Laboratory Evaluation Program (CLEP) administered by the New York State Department of Health (NYSDOH) and has been issued its clinical laboratory permit in the category Genetic Testing - Molecular.

Today, Cook Medical and Zelegent, Inc. announce an agreement to enhance treatment options for patients suffering from snoring.

NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205) and The University of Texas MD Anderson Cancer Center today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers.

Life of Purpose Addiction Treatment Centers announced the formation of the inaugural WOMEN’S PROJECT whose main purpose is to bring together women throughout the behavioral healthcare industry to celebrate, uplift, inform, educate, and solidify the critical contributions women in this industry provide to their clients, their families, and colleagues.

The world’s deadliest major cancer – pancreatic cancer – still has a five-year survival rate of just 9 percent, according to the Cancer Facts & Figures report released today by the American Cancer Society (ACS), and it is projected to become the second leading cause of cancer-related death in the United States as early as next year.

Fueling unique lifestyles with functional foods to help students live better lives

Dicerna Pharmaceuticals, Inc. today announced that on January 2, 2019, the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 182,000 shares of common stock to be distributed among nine new employees, with a grant date of January 2, 2019 (the “Inducement Grant”).

Centene Corporation today issued a reminder that it will release its 2018 fourth quarter and full year financial results at approximately 6 a.m. (Eastern Time) on Tuesday, February 5, 2019, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results.

CHADD and Russell A. Barkley, Ph.D., Partner to Announce Findings